Raymond James & Associates Lowers Stock Holdings in BlackRock Capital Allocation Term Trust (NYSE:BCAT)

Raymond James & Associates decreased its holdings in BlackRock Capital Allocation Term Trust (NYSE:BCATFree Report) by 80.5% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 115,443 shares of the company’s stock after selling 477,197 shares during the period. Raymond James & Associates’ holdings in BlackRock Capital Allocation Term Trust were worth $1,894,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also modified their holdings of the stock. UBS Group AG boosted its stake in shares of BlackRock Capital Allocation Term Trust by 8.2% in the 4th quarter. UBS Group AG now owns 1,543,167 shares of the company’s stock valued at $23,070,000 after buying an additional 116,638 shares during the period. Wells Fargo & Company MN increased its holdings in BlackRock Capital Allocation Term Trust by 0.9% in the fourth quarter. Wells Fargo & Company MN now owns 495,095 shares of the company’s stock valued at $7,402,000 after buying an additional 4,437 shares during the last quarter. Stifel Financial Corp increased its holdings in BlackRock Capital Allocation Term Trust by 30.3% in the fourth quarter. Stifel Financial Corp now owns 488,792 shares of the company’s stock valued at $7,307,000 after buying an additional 113,628 shares during the last quarter. Commonwealth Equity Services LLC raised its stake in BlackRock Capital Allocation Term Trust by 0.9% in the first quarter. Commonwealth Equity Services LLC now owns 227,639 shares of the company’s stock valued at $3,792,000 after buying an additional 1,950 shares in the last quarter. Finally, Advisors Asset Management Inc. lifted its holdings in BlackRock Capital Allocation Term Trust by 9.1% during the 1st quarter. Advisors Asset Management Inc. now owns 189,291 shares of the company’s stock worth $3,154,000 after buying an additional 15,763 shares during the last quarter. 36.12% of the stock is currently owned by institutional investors and hedge funds.

BlackRock Capital Allocation Term Trust Trading Down 0.6 %

BCAT opened at $16.49 on Wednesday. BlackRock Capital Allocation Term Trust has a one year low of $13.67 and a one year high of $17.18. The business’s 50-day simple moving average is $16.38 and its 200-day simple moving average is $16.12.

BlackRock Capital Allocation Term Trust Increases Dividend

The company also recently declared a monthly dividend, which was paid on Friday, August 30th. Shareholders of record on Thursday, August 15th were given a dividend of $0.287 per share. This is a positive change from BlackRock Capital Allocation Term Trust’s previous monthly dividend of $0.29. The ex-dividend date was Thursday, August 15th. This represents a $3.44 annualized dividend and a yield of 20.89%.

BlackRock Capital Allocation Term Trust Profile

(Free Report)

Featured Stories

Want to see what other hedge funds are holding BCAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Capital Allocation Term Trust (NYSE:BCATFree Report).

Institutional Ownership by Quarter for BlackRock Capital Allocation Term Trust (NYSE:BCAT)

Receive News & Ratings for BlackRock Capital Allocation Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Capital Allocation Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.